SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH M impact

Nautilus Biotechnology Q3'26 Earnings Preview: EPS Estimate at $(0.14)

Nautilus Biotechnology is scheduled to report Q3'26 results on October 27 before the market opens. EPS is expected at $(0.14).

NAUT

Related stories